Back to results
US 10,500,284 B2Granted
Pharmaceutical formulation
AssigneeSemnur Pharmaceuticals, Inc.
InventorMahendra G. Shah
Life of this patent
Estimating the term…
Abstract
Disclosed are aqueous pharmaceutical compositions which provide sustained released delivery of corticosteroid compounds. The pharmaceutical composition comprises a soluble corticosteroid and at least one viscosity enhancing agent. Also provided are methods for using the pharmaceutical compositions in an epidural injection, intra-articular injection, or an intra-lesional injection.
Claims29
An injectable aqueous pharmaceutical composition comprising:
- a soluble corticosteroid selected from the group consisting of soluble salts and esters of dexamethasone;
- and
- at least one viscosity enhancing agent,
- wherein the at least one viscosity enhancing agent is sodium hyaluronate or hyaluronic acid, the molecular weight of the at least one viscosity enhancing agent is between 1.0 MDa and 2.5 MDa, and the concentration of the at least one viscosity enhancing agent is between 1.0% w/v and 1.5% w/v;
- and wherein the injectable aqueous pharmaceutical composition does not comprise insoluble dexamethasone acetate.
2 more elements
A syringe comprising an injectable aqueous pharmaceutical composition, wherein the injectable aqueous pharmaceutical composition comprises:
- a soluble corticosteroid selected from the group consisting of soluble salts and esters of dexamethasone;
- and
- at least one viscosity enhancing agent,
- wherein the at least one viscosity enhancing agent is sodium hyaluronate or hyaluronic acid, the molecular weight of the at least one viscosity enhancing agent is between 1.0 MDa and 2.5 MDa, and the concentration of the at least one viscosity enhancing agent is between 1.0% w/v and 1.5% w/v;
- and wherein the injectable aqueous pharmaceutical composition does not comprise insoluble dexamethasone acetate.
2 more elements
Dependencies are inferred from the claim text.